期刊文献+

1-磷酸鞘氨醇调控血管功能在动脉粥样硬化中的研究进展

Progress in regulation of vascular function by sphingosine-1-phosphate in atherosclerosis
下载PDF
导出
摘要 在日常生活中,高血压、代谢综合征、吸烟和缺乏运动等条件可能诱发血管内皮细胞障碍^([1]),具体表现为内皮舒张功能受损、血管通透性增加、氧化应激和炎症等病理现象^([2]),正常内皮细胞的一个关键功能是防止血管黏附,内皮屏障异常导致内膜中形成包括各种细胞、脂质和组织碎屑在内的斑块,推动动脉粥样硬化的发展^([1])。 Sphingosine-1-phosphate(S1P)is a bioactive lipid that regulates a variety of physiological processes,including immune surveillance,immune cell transport,vascular development,and cell differentiation.S1P also plays an important role in regulating vascular function and balancing endothelial barrier homeostasis.The majority of S1P molecules are located in their chaperone proteins,such as apolipoprotein M or albumin.The chaperone protein is also a carrier and modulator of S1P molecules,and the combination of the two can protect the S1P structure.S1P-binding chaperone protein selectively activates S1P receptor in the form of a complex that opens downstream pathways by coupling with different S1P receptor targets to exert its effects in vivo.The present review elucidates the metabolism and function of S1P,as well as the effect of chaperones on its function,and clarifies the regulation of S1P in vascular activity and pathogenesis of atherosclerosis.
作者 吴婧 施媛萍 WU Jing;SHI Yuanping(Clinical Medical Research Center,The Third Affiliated Hospital of Soochow University,Changzhou 213003,China)
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2023年第12期2288-2295,共8页 Chinese Journal of Pathophysiology
基金 分子发育生物学国家重点实验室开放课题(No.2022-MDB-KF-17) 常州市国际科技合作计划(No.CZ20220024) 常州市“十四五”卫生健康高层次人才培养工程拔尖人才(No.2022260)。
关键词 1-磷酸鞘氨醇 载脂蛋白M 白蛋白 血管功能 内皮细胞屏障 动脉粥样硬化 sphingosine-1-phosphate apolipoprotein M albumin vascular function endothelial barrier atherosclerosis
  • 相关文献

参考文献3

二级参考文献23

  • 1Kontush A, Chapman MJ. Functionally defective high- density lipoprotein: a new therapeutic target at the cross- roads of dyslip~demia, inflammation, and atherosclerosis [J]. Pharmacol Rev, 2006, 58(3) :342-374.
  • 2Takuwa Y, Okamoto Y, Yoshioka K, et al. Sphingosine- 1-phosphate signaling in physiology and diseases[ J]. Bio- factors, 2012, 38(5) :329-337.
  • 3Levkau B. Cardiovascular effects of sphingosine-1-phos- phate (SIP)[ J]. Handb Exp Pharmacol, 2013, 216 (6) :147-170.
  • 4Christoffersen C, Obinata H, Kumaraswamy SB, et al. Endothelium-protective sphingosine-l-phosphate provided by HDL-associated apolipoprotein M [ J]. Proc Natl Acad Sci U S A, 2011, 108(23) :9613-9618.
  • 5Jiang XC, Qin S, Qiao C, et al. Apolipoprotein B secre- tion and atherosclerosis are decreased in mice with phos- pholipid-transfer protein deficiency [ J]. Nat Med, 2001, 7(7) :847-852.
  • 6Attia N, Nakbi A, Smaoui M, et al. Increased phospho- lipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease [ J ]. Tohoku J Exp Med, 2007, 213(2) :129-137.
  • 7Sattler KJ, Elbasan S, Keul P, et al. Sphingosine 1-phos- phate levels in plasma and HDL are altered in coronary ar- tery disease[J]. Basic Res Cardiol, 2010, 105(6) :821- 832.
  • 8Faber K, Axler O, Dahlback B, et al. Characterization of apoM in normal and genetically modified mice [ J ]. J Lipid Res, 2004, 45(7):1272-1278.
  • 9Oram JF, Wolfbauer G, Tang C, et al. An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCAl-dependent cholesterol efflux[J]. J Biol Chem, 2008, 283(17):11541-11549.
  • 10Robins S J, Lyass A, Brocia RW, et al. Plasma lipid transfer proteins and cardiovascular disease. The Framing- ham Heart Study [ J ]. Atherosclerosis, 2013,228 ( 1 ) : 230- 236.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部